12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Challenges in implementing uncomplicated malaria treatment in children: a health facility survey in rural Malawi

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Prompt and effective malaria treatment are key in reducing transmission, disease severity and mortality. With the current scale-up of artemisinin-based combination therapy (ACT) coverage, there is need to focus on challenges affecting implementation of the intervention. Routine indicators focus on utilization and coverage, neglecting implementation quality. A health system in rural Malawi was assessed for uncomplicated malaria treatment implementation in children.

          Methods

          A cross-sectional health facility survey was conducted in six health centres around the Majete Wildlife Reserve in Chikwawa district using a health system effectiveness approach to assess uncomplicated malaria treatment implementation. Interviews with health facility personnel and exit interviews with guardians of 120 children under 5 years were conducted.

          Results

          Health workers appropriately prescribed an ACT and did not prescribe an ACT to 73% (95% CI 63–84%) of malaria rapid diagnostic test (RDT) positive and 98% (95% CI 96–100%) RDT negative children, respectively. However, 24% (95% CI 13–37%) of children receiving artemisinin–lumefantrine had an inappropriate dose by weight. Health facility findings included inadequate number of personnel (average: 2.1 health workers per 10,000 population), anti-malarial drug stock-outs or not supplied, and inconsistent health information records. Guardians of 59% (95% CI 51–69%) of children presented within 24 h of onset of child’s symptoms.

          Conclusion

          The survey presents an approach for assessing treatment effectiveness, highlighting bottlenecks which coverage indicators are incapable of detecting, and which may reduce quality and effectiveness of malaria treatment. Health service provider practices in prescribing and dosing anti-malarial drugs, due to drug stock-outs or high patient load, risk development of drug resistance, treatment failure and exposure to adverse effects.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: not found
          • Article: not found

          Guidelines for the treatment of malaria

          (2015)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Factors influencing healthcare service quality.

            The main purpose of this study was to identify factors that influence healthcare quality in the Iranian context.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Artesunate combinations for treatment of malaria: meta-analysis.

              Addition of artemisinin derivatives to existing drug regimens for malaria could reduce treatment failure and transmission potential. We assessed the evidence for this hypothesis from randomised controlled trials. We undertook a meta-analysis of individual patients' data from 16 randomised trials (n=5948) that studied the effects of the addition of artesunate to standard treatment of Plasmodium falciparum malaria. We estimated odds ratios (OR) of parasitological failure at days 14 and 28 (artesunate combination compared with standard treatment) and calculated combined summary ORs across trials using standard methods. For all trials combined, parasitological failure was lower with 3 days of artesunate at day 14 (OR 0.20, 95% CI 0.17-0.25, n=4504) and at day 28 (excluding new infections, 0.23, 0.19-0.28, n=2908; including re-infections, 0.30, 0.26-0.35, n=4332). Parasite clearance was significantly faster (rate ratio 1.98, 95% CI 1.85-2.12, n=3517) with artesunate. In participants with no gametocytes at baseline, artesunate reduced gametocyte count on day 7 (OR 0.11, 95% CI 0.09-0.15, n=2734), with larger effects at days 14 and 28. Adding artesunate for 1 day (six trials) was associated with fewer failures by day 14 (0.61, 0.48-0.77, n=1980) and day 28 (adjusted to exclude new infections 0.68, 0.53-0.89, n=1205; unadjusted including reinfections 0.77, 0.63-0.95, n=1958). In these trials, gametocytes were reduced by day 7 (in participants with no gametocytes at baseline 0.11, 0.09-0.15, n=2734). The occurrence of serious adverse events did not differ significantly between artesunate and placebo. The addition of 3 days of artesunate to standard antimalarial treatments substantially reduce treatment failure, recrudescence, and gametocyte carriage.
                Bookmark

                Author and article information

                Contributors
                akabaghe@medcol.mw
                mdphiri@mlw.mw
                kamijaphiri@gmail.com
                m.vanvugt@amc.uva
                Journal
                Malar J
                Malar. J
                Malaria Journal
                BioMed Central (London )
                1475-2875
                18 October 2017
                18 October 2017
                2017
                : 16
                : 419
                Affiliations
                [1 ]ISNI 0000000404654431, GRID grid.5650.6, Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, , Academic Medical Center, University of Amsterdam, ; Meibergdreef 9, PO Box 22700, 1100 DE Amsterdam, The Netherlands
                [2 ]ISNI 0000 0001 2113 2211, GRID grid.10595.38, Public Health Department, , College of Medicine, ; Private Bag 360, Blantyre, Malawi
                [3 ]ISNI 0000 0004 0598 3456, GRID grid.415487.b, Ministry of Health, , Queen Elizabeth Central Hospital, ; P.O. Box 95, Blantyre, Malawi
                [4 ]GRID grid.419393.5, Malawi-Liverpool Wellcome Trust, ; P.O Box 30096, Blantyre, Malawi
                Article
                2066
                10.1186/s12936-017-2066-7
                5648442
                29047388
                44a8d9b1-4b64-4cd6-8a7e-5da1a3e0f031
                © The Author(s) 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 4 January 2017
                : 16 October 2017
                Funding
                Funded by: Dioraphte Foundation, Netherlands
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Infectious disease & Microbiology
                malaria,health systems,clinical decision making,care-seeking
                Infectious disease & Microbiology
                malaria, health systems, clinical decision making, care-seeking

                Comments

                Comment on this article